XML 295 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated statement of comprehensive income - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Other comprehensive income      
Net profit € 6,369 € 7,140 € 8,269
Items that will not be reclassified to profit or loss, net of tax:      
Gains/(losses) on equity instruments measured at fair value through other comprehensive income 60 (28) 36
Remeasurement of defined benefit pension plans 264 (510) (473)
Items that may be reclassified subsequently to profit or loss, net of tax:      
Gains/(losses) on cash flow hedges 210 (27) (91)
Currency retranslation gains/(losses) [1],[2] 1,389 (1,461) 614
Total comprehensive income 8,292 5,114 8,355
Attributable to:      
Non-controlling interests 712 524 507
Shareholders’ equity € 7,580 € 4,590 € 7,848
[1] (a)Includes a hyperinflation adjustment of €880 million (2023: €308 million, 2022: €514 million) in relation to Argentina and Turkey.(b)
[2] 2024 net loss arises from the disposals of our Russian business, Elida Beauty, Pureit, and Qinyuan. This net loss includes a foreign currency translation reserve write-off of €545 million.
2023 includes a gain of €497 million related to the disposal of Suave. 2022 includes a gain of €2,303 million related to the disposal of the global tea business.